Director, Global Value and Health Economics, Outcomes Research

🔥 1 minute ago

🏄 California, Pennsylvania – Remote

🏄 California – Remote 🔔 Pennsylvania – Remote

💵 $212k - $318k / year

⏰ Full Time

🔴 Lead

👔 Director

🦅 H1B Visa Sponsor

This company has sponsored H1B visas in the past.

👻 Ghost score 0%

What it means: the chance that no one is really hiring for this job.How to read it: 60% or higher means we think this is a ghost. Lower scores are less of a worry.How we score it: age, reposts, open roles vs team size, how fast jobs close, and whether pay is listed.Fine print: an estimate from public data, not a judgment of the company. Real jobs can score high, so treat it as a hint, not a fact.

Apply Now

Find Similar Remote Jobs

Jazz Pharmaceuticals

WebsiteLinkedInAll Job Openings

1001 - 5000 employees

Founded 2003

🏥 Healthcare

🏭 Manufacturing

🧬 Biotechnology

Healthcare • Manufacturing • Biotechnology

Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.

📋 Description

• Define and execute global and US payer evidence strategies in Oncology • Lead global HEOR activities and strategies in gastroesophageal adenocarcinoma and support a major Oncology asset’s clinical pipeline • Embed payer, HTA, and reimbursement requirements into Phase 2 and Phase 3 clinical development programs • Serve as US HEOR lead for commercial, Medicare Part B/D, and Medicaid access • Execute and author AMCP dossiers, US commercial/Medicare budget impact models, and state Medicaid submission packages • Enable US Payer Field Teams with interactive economic models, slide decks, and digital tools • Monitor US health policy and prepare evidence roadmaps for IRA, CMS Drug Price Negotiation, Part D redesign, ICER reviews, and NCCN Evidence Blocks • Advise on innovative payment models and value-based contracts • Design and execute health economic models, including CEA, CUA, and BIM, across the product lifecycle • Direct global core economic model architecture and validation • Lead global value dossiers, systematic literature reviews, global evidence libraries, ITCs, NMAs, and economic model adaptations • Collaborate on real-world evidence, natural history, burden-of-illness, treatment-pattern, and comparative-effectiveness studies • Lead HEOR launch readiness, lifecycle management, label expansion, value defense, and post-launch evidence programs • Govern HEOR commitments in Integrated Evidence Generation Plans • Partner with Market Access, Brand Teams, Medical Affairs, Clinical Development, Regulatory, Commercial, and EU/INT HEOR teams • Lead publications and presentations at scientific and health economic congresses • Mentor junior scientists, cross-functional colleagues, and HEOR fellows • Ensure compliance with legal, regulatory, and corporate standards

🎯 Requirements

• Master’s degree (MSc, MS, MPH, PhD) in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Experience with oncology assets preferred • Track record leading HEOR strategy and executing evidence deliverables for marketed, inline pharmaceutical products, including lifecycle management, label expansions, and value defense • Deep understanding of US payers and population health decision makers, including Oncology Pathways • Experience managing regional trade-offs on evidence needs during Phase 2/3 protocol development • Launch lead for at least 2 assets as US HEOR lead or country-level HTA lead • Proven track record as US HEOR lead or driving US pre-launch HEOR deliverables, including AMCP PIE dossiers, US budget impact models, and payer field enablement • Experience conducting post-marketing RWE, patient registry studies, and economic evaluations in rare diseases, specialized medicine, or complex chronic conditions • Experience collaborating with regional HEOR teams, such as EU/INT, on global HTA reassessments, renewals, or pricing renegotiations • Strong peer-reviewed publication record in health economics and outcomes research • Deep knowledge of US managed care archetypes and international HTA systems • Advanced expertise in health economic modeling, including Markov, partitioned survival, microsimulation, and discrete event simulation • Track record partnering with US Payer Field Teams to develop interactive economic models and value presentation tools • Practical rare disease/orphan drug access expertise • Experience with launch readiness, lifecycle management, clinical trial design, policy, value assessments, matrix leadership, mentorship, project, budget, and vendor management • Familiarity with FDAMA Section 114, 21st Century Cures Act, EU JCA, NICE, G-BA, and CADTH

🏖️ Benefits

• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants through the Long Term Equity Incentive Plan • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume